0001104659-20-011268.txt : 20200205 0001104659-20-011268.hdr.sgml : 20200205 20200205163852 ACCESSION NUMBER: 0001104659-20-011268 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200203 FILED AS OF DATE: 20200205 DATE AS OF CHANGE: 20200205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COLA MICHAEL F CENTRAL INDEX KEY: 0001188940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37590 FILM NUMBER: 20579308 MAIL ADDRESS: STREET 1: 435 DEVON PARK BUILDING 800 CITY: WAYNE STATE: PA ZIP: 19087-1945 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerecor Inc. CENTRAL INDEX KEY: 0001534120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450705648 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 410-522-8707 MAIL ADDRESS: STREET 1: 540 GAITHER ROAD STREET 2: SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 tm206826d3_4.xml OWNERSHIP DOCUMENT X0306 4 2020-02-03 0 0001534120 Cerecor Inc. CERC 0001188940 COLA MICHAEL F C/O AEVI GENOMIC MEDICINE, LLC 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 1 1 0 0 Chief Executive Officer Common Stock 2020-02-03 4 A 0 75746 A 75746 D Stock Option (Right to Buy) 3.98 2020-02-03 4 A 0 1200000 0 A 2030-02-03 Common Stock 1200000 1200000 D Received in exchange for 2,267,859 shares of Aevi Genomic Medicine, Inc. ("Aevi") common stock in connection with the merger of Aevi into a wholly owned subsidiary of the issuer pursuant to the previously announced Agreement and Plan of Merger and Reorganization by and among Aevi, Genie Merger Sub, Inc., Second Merger Sub, LLC and the issuer. The stock option will vest over four years, with the first 25% vesting on the first anniversary of the grant date, and the remainder vesting in equal monthly installments, subject to the reporting person's continued service on each such vesting date. /s/ Michael McInaw, by Power of Attorney 2020-02-05